Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database


Kelestimur F. , Jonsson P., Molvalilar S., Gomez J., Auernhammer C., Colak R., ...More

EUROPEAN JOURNAL OF ENDOCRINOLOGY, vol.152, no.4, pp.581-587, 2005 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 152 Issue: 4
  • Publication Date: 2005
  • Doi Number: 10.1530/eje.1.01881
  • Title of Journal : EUROPEAN JOURNAL OF ENDOCRINOLOGY
  • Page Numbers: pp.581-587

Abstract

Objective: Sheehan's syndrome occurs as a result of ischaemic pituitary necrosis due to severe postpartum haemorrhage. It is one of the most important causes of hypopituitarism. and hence growth hormone deficiency (GHD), in developing countries. However, little is known about the effects of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.